Click here to create your personal news page. The news that appears on Drug Manufacturers will appear there and be constantly updated. You can then modify the page, share it with your friends, or export it and have it appear elsewhere.

You can also create a personal news page and follow the news that interests you by clicking on the tab labelled 'New page'.
 

topics : related - allExplore

Wikio Shopping (beta)

  1. 1. Computers
  2. 2. Electronics
  3. 3. Communication
  4. 4. Household Appliances
  5. 5. Car/Motor Bike
  6. 6. Digital Camera
  7. 7. Mobile Phone
  8. 8. Smartphone
  9. 9. PDA
  10. 10. GPS
  11. 11. LCD Monitor
  12. 12. Printer

New products

  1. 1. Storex AivX-385HDRW 750 GB
  2. 2. Lexmark X4650
  3. 3. Creative Sound Blaster X-Fi Surround 5.1
  4. 4. Logitech Cordless MediaBoard Pro (Playstation 3)
  5. 5. Point Of View GeForce 9600 GSO
  6. 6. LG KM501
  7. 7. Arctic Cooling Accelero Xtreme 9800
  8. go to Shopping

Participate



Drug Manufacturers


Sort by : relevance - date - popularity
+Vote!

Drug Company Petition Seeks to Eliminate the Competition

Drugmaker GlaxoSmithKline has petitioned the FDA to classify weight loss claims for dietary supplements as disease claims. Many say that this is nothing more than an attempt by the makers of alli, an over-the-counter weight loss drug, to quash competition from the supplement weight loss industry. It is yet another instance of a pharmaceutical giant using its considerable monetary, legal and political...

+Vote!

Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug

The company said it would resubmit its application for Multaq based on results from a study showing that the drug reduced both hospitalization and death in patients with atrial fibrillation.

+Vote!

Jordan's Hikma avoids contaminants by using cattle instead of pig products

The Islamic principles of a generic drugs company have provided it with an unexpected marketing advantage, following the discovery of contaminants in a leading...

+Vote!

FDA Issues Transplant Drug Warning

Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.

+Vote!

Experimental Novartis drug slows kidney cancer

WASHINGTON (Reuters) - An experimental drug from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy, researchers reported on Friday.

+Vote!

Experimental Novartis drug slows kidney cancer

WASHINGTON (Reuters) - An experimental drug from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy, researchers reported on Friday.

+Vote!

FDA reissues warning about transplant drug

Health regulators warned again today that Roche and Novartis drugs prescribed to organ transplant...

+Vote!

IIR "Generic Drugs Summit," Washington, D.C., June 18-20

The Institute for International Research will be holding its 9th annual "Generic Drugs Summit," June 18-20 in Washington, D.C. According to IIR, this is "the leading independent forum addressing business and legal concerns impacting the generics marketplace. This event attracts...

+Vote!

FDA Warns of Birth Defects With Drugs

Health regulators warned again that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.

+Vote!

FDA stresses birth defect risks with Roche drug

Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages ...

+Vote!

FDA stresses birth defect risks with Roche drug

Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages and birth defects when used by pregnant women. The Food and Drug Administration previously said it received reports of miscarriages...

+Vote!
+Vote!

Sacrebleu!

Up to 32,000 Big Pharma jobs could be axed in France over the next few years, according to a study commissioned by Leem, the French pharmaceutical industry body. The Arthur D. Little study names five major factors threatening the pharmaceutical model: pricing pressures; generics; changing areas of growth, the break up of the traditional value chain as a result of the rise of biotechnology;...

+Vote!

Rumor Mill: Pfizer Buying MediGene?

Eben Tessari submits: German-based MediGene hit a 52 week high yesterday on rumors that they are in discussions with the drug giant Pfizer (PFE). MediGene is just the latest of half a dozen companies mentioned in the same sentence as Pfizer in the last few months (others include Biogen, Shire, King and NicOx). In the past year, many analysts have urged Pfizer to consider buying a midsized drug maker...

+Vote!

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Citi Conference

ROCKVILLE, Md., May 16 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: ) announced today that its presentation at the 2008 Citi Investment Research Global Healthcare Conference will be webcast and may be accessed at (Logo: ) A member of Human Genome Sciences' senior management team will present a corporate overview on Wednesday, May 21, 2008 at 3:00 pm Eastern Time. Investors...

The 3 the latest comments published by users on Drug Manufacturers :

1Vote!

Contract Research and Manufacturing Services - India (CRAMS)

The global pharmaceutical industry is at the cross roads. With many of the blockbuster drugs getting off-patented and with increasing R&D costs, it's hard by the companies to maintain their bottom-line and remain unaffected. They have found recourse to outsourcing some of their research and manufacturing activities and saving cost in the process. This has led to the growth of contract research and...

+Vote!

Indian Pharmaceuticals Industry Report

Pharmaceutical business is a blend of commerce and public service. Globally, the pharmaceutical industry grew at a compounded annual growth rate (CAGR) of 9.1 per cent in the last 23 years- powered by a string of innovative blockbusters. It is an industry characterized by huge investments in drug discovery and development. In the recent past, falling research productivity triggered off a series of...

2Vote!

Biogenerics: Not yet a Reality in the U.S.

Biologic products grew at an average clip of 17% over the past two years, a growth higher than any other sub-sector within the pharmaceutical industry. There are many biologics in the approval pipeline and it has been projected that 50% of drugs approved for the marketplace in 2010 will be the result of biotechnology. Biologic medicines, manufactured from complex living cells, provide some of the